PND109 PATIENT PREFERENCE FOR DOSING REGIMEN AND PERCEPTION OF DOSING FLEXIBILITY WITH FREMANEZUMAB FOR CHRONIC OR EPISODIC MIGRAINE: RESULTS FROM A WEB-BASED, PATIENT SURVEY FOLLOWING COMPLETION OF A 1-YEAR EXTENSION STUDY
Cowan, R.P., Gandhi, S.K., Cloud, B., Cohen, J., Buse, D.C., Ramirez-Campos, V., Ahn, A.H., Lipton, R.B.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article